These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2620451)

  • 1. The relationship of plasma acetate with glucose and other blood intermediary metabolites in non-diabetic and diabetic subjects.
    Akanji AO; Humphreys S; Thursfield V; Hockaday TD
    Clin Chim Acta; 1989 Oct; 185(1):25-34. PubMed ID: 2620451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma acetate levels in response to intravenous fat or glucose/insulin infusions in diabetic and non-diabetic subjects.
    Akanji AO; Ng L; Humphreys S
    Clin Chim Acta; 1988 Nov; 178(1):85-94. PubMed ID: 3067912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of acetate on blood metabolites and glucose tolerance during haemodialysis in uraemic non-diabetic and diabetic subjects.
    Akanji AO; Sacks S
    Nephron; 1991; 57(2):137-43. PubMed ID: 2020339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of obesity on circulating intermediary metabolite concentrations in the absence of impaired glucose tolerance.
    Robertson DA; Singh BM; Nattrass M
    Int J Obes; 1991 Oct; 15(10):635-45. PubMed ID: 1752724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in plasma acetate levels in diabetic subjects on mixed high fiber diets.
    Akanji AO; Peterson DB; Humphreys S; Hockaday TD
    Am J Gastroenterol; 1989 Nov; 84(11):1365-70. PubMed ID: 2554722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal regulation of intermediary metabolism after oral glucose ingestion in myotonic dystrophy.
    Krentz AJ; Coles NH; Williams AC; Nattrass M
    Metabolism; 1990 Sep; 39(9):938-42. PubMed ID: 2202885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic and hormonal response to acute normoglycaemia in type 1 (insulin-dependent) diabetes: studies with a glucose controlled insulin infusion system (artificial endocrine pancreas).
    Nosadini R; Noy GA; Nattrass M; Alberti KG; Johnston DG; Home PD; Orskov H
    Diabetologia; 1982 Sep; 23(3):220-8. PubMed ID: 6751902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic effects of low-dose incremental insulin infusion in diabetic man.
    Hale PJ; Black E; Nattrass M
    Horm Metab Res; 1986 Feb; 18(2):129-33. PubMed ID: 3516823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent abnormalities of the metabolism of an oral glucose load in insulin-treated type I diabetics.
    Benn JJ; Bozzard SJ; Kelley D; Mitrakou A; Aoki T; Sorensen J; Gerich J; Sonksen PH
    Metabolism; 1989 Nov; 38(11):1047-55. PubMed ID: 2682133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic effects of aldose reductase inhibition in diabetic man.
    Krentz AJ; Ellis SH; Hardman M; Nattrass M
    Diabetes Res; 1992 Jan; 19(1):41-8. PubMed ID: 1468186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of acetate on ketogenesis during hemodialysis.
    Desch G; Polito C; Descomps B; Mion CM; Crastes de Paulet A
    J Lab Clin Med; 1982 Jan; 99(1):98-107. PubMed ID: 7033422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The short-term effect of nicotinic acid on intermediary metabolism in insulin-dependent diabetes mellitus.
    Hale PJ; Nattrass M
    Ann Clin Biochem; 1991 Jan; 28 ( Pt 1)():39-43. PubMed ID: 2024932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular lactate- and pyruvate-interconversion rates are increased in muscle tissue of non-insulin-dependent diabetic individuals.
    Avogaro A; Toffolo G; Miola M; Valerio A; Tiengo A; Cobelli C; Del Prato S
    J Clin Invest; 1996 Jul; 98(1):108-15. PubMed ID: 8690781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High blood ketone body concentration in type 2 non-insulin dependent diabetic patients.
    Avogaro A; Crepaldi C; Miola M; Maran A; Pengo V; Tiengo A; Del Prato S
    J Endocrinol Invest; 1996 Feb; 19(2):99-105. PubMed ID: 8778173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired glucose tolerance is characterized by multiple abnormalities in the regulation of intermediary metabolism.
    Krentz AJ; Singh BM; Nattrass M
    Diabet Med; 1991 Nov; 8(9):848-54. PubMed ID: 1837511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous subcutaneous insulin infusion fails to correct impaired basal glucose metabolism and impaired insulin sensitivity of adipocytes from patients with type 1 (insulin-dependent) diabetes.
    Pedersen O; Hjøllund E; Beck-Nielsen H; Richelsen B; Sørensen NS
    Diabetes Res; 1986 Jan; 3(1):17-23. PubMed ID: 3514067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolic response to hyperglycaemic clamping in insulin-dependent diabetes.
    Nosadini R; Noy GA; Alberti KG; Hodson A; Orskoy H
    Diabetologia; 1981 Feb; 20(2):113-7. PubMed ID: 7009290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbohydrate, lipid and amino acid metabolism of insulin-dependent diabetic patients regulated by an artificial beta-cell unit.
    Foss MC; Vlachokosta FV; Aoki TT
    Diabetes Res; 1989 May; 11(1):1-8. PubMed ID: 2695278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic abnormalities in obese patients with impaired glucose tolerance.
    Robertson DA; Singh BM; Baddeley RM; Nattrass M
    Diabet Med; 1990 Jan; 7(1):45-9. PubMed ID: 2137062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic rhythms in adolescents with diabetes.
    Hocking MD; Rayner PH; Nattrass M
    Arch Dis Child; 1986 Feb; 61(2):124-9. PubMed ID: 3954437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.